summary
Introduced
01/13/2025
01/13/2025
In Committee
06/25/2025
06/25/2025
Crossed Over
06/23/2025
06/23/2025
Passed
07/25/2025
07/25/2025
Dead
Signed/Enacted/Adopted
07/25/2025
07/25/2025
Introduced Session
2025 Legislative Measures
Bill Summary
AN ACT Relating to step therapy for nonopioids; creating new provisions; and amending ORS 414.361, 750.055 and 750.333.
AI Summary
This bill requires health care coverage providers to ensure that their drug formularies include at least one clinically appropriate nonopioid prescription drug as an alternative for each opioid prescription drug. The bill defines key terms such as "clinically appropriate" (supported by recognized medical guidelines) and "nonopioid prescription drug" (FDA-approved pain medication that is not an opioid). It mandates that coverage for nonopioid alternatives must be no more restrictive than the coverage for opioid drugs, including requirements for prior authorization, step therapy, cost-sharing, and other utilization review processes. The legislation applies to health benefit plans, health care service contracts, and multiple employer welfare arrangements issued or renewed after its effective date. Additionally, the bill includes provisions to increase expenditure limits for the Public Employees' Benefit Board and the Oregon Educators Benefit Board to support equitable nonopioid prescription drug coverage, with allocations of $541,508 and $258,652 respectively for the 2025-2027 biennium.
Committee Categories
Budget and Finance, Education, Health and Social Services
Sponsors (7)
Wlnsvey Campos (D)*,
Willy Chotzen (D),
Dacia Grayber (D),
Em Levy (D),
Travis Nelson (D),
Rob Nosse (D),
Deb Patterson (D),
Last Action
Effective date, January 1, 2026. (on 07/25/2025)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...